Evidence map›Paper›PMID 36862503›Full record

ArticleThe Journal of clinical investigation2023

CEP162 deficiency causes human retinal degeneration and reveals a dual role in ciliogenesis and neurogenesis.

Nafisa Nuzhat, Kristof Van Schil, Sandra Liakopoulos, Miriam Bauwens, Alfredo Dueñas Rey, Stephan Käseberg, Melanie Jäger, Jason R Willer, Jennifer Winter, Hanh M Truong and 23 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Ciliary Defects in Inherited Retinal Diseases.Advanced genetics (Hoboken, N.J.) · 2026
    Review
  3. Article
  4. The kinesin-4 protein KIF27 forms a cytoskeletal scaffold at the transition zone to promote motile cilia structural integrity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 10 institutions in 4 countries.

Nafisa NuzhatDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA.
Kristof Van SchilDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Sandra LiakopoulosCologne Image Reading Center, Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
Miriam BauwensDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Alfredo Dueñas ReyDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Stephan KäsebergInstitute of Human Genetics, University Medical Center Mainz, Mainz, Germany.
Melanie JägerDepartment of Ophthalmology, Justus-Liebig-University Giessen, Giessen, Germany.
Jason R WillerDepartment of Ophthalmology and.
Jennifer WinterInstitute of Human Genetics, University Medical Center Mainz, Mainz, Germany.
Hanh M TruongCell and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan, USA.
Nuria GruartmonerDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Mattias Van HeetveldeDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Joachim WolfDepartment of Radiology and.
Robert MergetDepartment of Radiology and.
Sabine Grasshoff-DerrDepartment of Pediatric Surgery, Bürgerhospital, Frankfurt am Main, Germany.
Jo Van DorpeDepartment of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Anne HoorensDepartment of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Heidi StöhrInstitute of Human Genetics, University of Regensburg, Regensburg, Germany.
Luke MansardLaboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.
Anne-Françoise RouxLaboratoire de Génétique Moléculaire, CHU de Montpellier, Université de Montpellier, Montpellier, France.
Thomas LangmannLaboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Katharina DannhausenLaboratory for Experimental Immunology of the Eye, Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
David RosenkranzSenckenberg Centre for Human Genetics, Frankfurt am Main, Germany.
Karl M WissingDepartment of Nephrology and.
Michel Van LintDepartment of Ophthalmology, Brussels University Hospital, Jette, Belgium.
Heidi RossmannInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.
Friederike HäuserInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.
Peter NürnbergCologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Holger ThieleCologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Ulrich ZechnerInstitute of Human Genetics, University Medical Center Mainz, Mainz, Germany.
Jillian N PearringDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA.
Elfride De BaereDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Hanno J BolzSenckenberg Centre for Human Genetics, Frankfurt am Main, Germany.
Ghent University Hospital · BEJohannes Gutenberg University Mainz · DEUniversity Hospital Cologne · DEUniversity of Michigan · USUniversité de Montpellier · FRUniversity of Cologne · DEBürgerhospital Frankfurt am Main · DEGoethe University Frankfurt · DEJustus-Liebig-Universität Gießen · DEUniversity of Regensburg · DE

Funding

VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
TRAINING PROGRAM IN ORGANOGENESIST32HD007505 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PASCA DI MAGLIANO, MARINA, SPENCE, JASON · 1997 to 2021
$6.9M
E75 IN THE DEVELOPING DROSOPHILA EYEF31EY007003 · NEI · YALE UNIVERSITY · PI SHILTON, ALYCIA N · 1999 to 2001
$14k
NEI NIH HHS F31 EY007003NEI NIH HHS P30 EY007003NICHD NIH HHS T32 HD007505
6 · The paper itself

Abstract

Defects in primary or motile cilia result in a variety of human pathologies, and retinal degeneration is frequently associated with these so-called ciliopathies. We found that homozygosity for a truncating variant in CEP162, a centrosome and microtubule-associated protein required for transition zone assembly during ciliogenesis and neuronal differentiation in the retina, caused late-onset retinitis pigmentosa in 2 unrelated families. The mutant CEP162-E646R*5 protein was expressed and properly localized to the mitotic spindle, but it was missing from the basal body in primary and photoreceptor cilia. This impaired recruitment of transition zone components to the basal body and corresponded to complete loss of CEP162 function at the ciliary compartment, reflected by delayed formation of dysmorphic cilia. In contrast, shRNA knockdown of Cep162 in the developing mouse retina increased cell death, which was rescued by expression of CEP162-E646R*5, indicating that the mutant retains its role for retinal neurogenesis. Human retinal degeneration thus resulted from specific loss of the ciliary function of CEP162.

Indexed as

Retinal DegenerationAdenosine TriphosphatasesAnimalsCentrosomeCiliaHumansMiceMicrotubule-Associated ProteinsNeurogenesisRetinaAdenosine TriphosphatasesCEP162 protein, humanMicrotubule-Associated ProteinsCell BiologyGenetic diseasesGeneticsMolecular geneticsRetinopathy

Identifiers

PMID36862503
PMCPMC10104899
OpenAlexW4322757113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.